Passage Bio Inc (PASG) USD0.0001
Sell:$0.33Buy:$0.36
$0.01
(4.00%)
Prices delayed by at least 15 minutes
- This stock can be held in a
Stocks and Shares ISASell:$0.33
Buy:$0.36
Change:$0.01
(4.00%)
$0.01
(4.00%)Prices delayed by at least 15 minutes
Sell:$0.33
Buy:$0.36
Change:$0.01
(4.00%)
$0.01
(4.00%)Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 17 April 2025 | ORBIMED ADVISORS LLCPrivate Equity | Sell Regular sell transaction (market) | 77,090 | $0.33 | $25,439.70 | 6,885,572 |
| 16 April 2025 | ORBIMED ADVISORS LLCPrivate Equity | Sell Regular sell transaction (market) | 61,638 | $0.33 | $20,340.54 | 6,962,662 |
| 15 April 2025 | ORBIMED ADVISORS LLCPrivate Equity | Sell Regular sell transaction (market) | 10,326 | $0.38 | $3,923.88 | 7,024,300 |
| 11 February 2025 | Kathleen BorthwickCFO | Sell Tax related | 3,183 | $0.53 | $1,685.72 | 41,283 |
| 14 January 2025 | ORBIMED ADVISORS LLCPrivate Equity | Sell Regular sell transaction (market) | 79,024 | $0.60 | $47,414.40 | 7,034,626 |
| 13 January 2025 | ORBIMED ADVISORS LLCPrivate Equity | Sell Regular sell transaction (market) | 17,986 | $0.64 | $11,511.04 | 7,113,650 |
| 10 January 2025 | ORBIMED ADVISORS LLCPrivate Equity | Sell Regular sell transaction (market) | 126,209 | $0.66 | $83,297.94 | 7,131,636 |
| 8 January 2025 | ORBIMED ADVISORS LLCPrivate Equity | Sell Regular sell transaction (market) | 75,007 | $0.68 | $51,004.76 | 7,257,845 |
| 7 January 2025 | ORBIMED ADVISORS LLCPrivate Equity | Sell Regular sell transaction (market) | 52,536 | $0.71 | $37,300.56 | 7,332,852 |
| 6 January 2025 | ORBIMED ADVISORS LLCPrivate Equity | Sell Regular sell transaction (market) | 19,481 | $0.77 | $15,000.37 | 7,385,388 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 27 December 2024 | LYNX1 CAPITAL MANAGEMENT LPHedge Fund | Buy Regular purchase transaction | 373,645 | $0.65 | $241,038.39 | 9,256,953 |
| 25 November 2024 | LYNX1 CAPITAL MANAGEMENT LPHedge Fund | Buy Regular purchase transaction | 259,998 | $0.56 | $146,664.87 | 8,686,953 |
| 20 December 2024 | ORBIMED ADVISORS LLCPrivate Equity | Sell Regular sell transaction (market) | 230,321 | $0.60 | $138,192.60 | 7,404,869 |
| 26 November 2024 | LYNX1 CAPITAL MANAGEMENT LPHedge Fund | Buy Regular purchase transaction | 167,055 | $0.71 | $118,191.41 | 8,854,008 |
| 10 January 2025 | ORBIMED ADVISORS LLCPrivate Equity | Sell Regular sell transaction (market) | 126,209 | $0.66 | $83,297.94 | 7,131,636 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.